<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/44659/sun-pharmaceutical-industries-ltd/rss/" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>A hunt for quality large caps available cheap</title>
			<link>https://www.valueresearchonline.com/stories/47397/a-hunt-for-quality-large-caps-available-cheap/</link>
			<pubDate>Wed, 09 Oct 2019 13:22:11 +0530</pubDate>
			<category>Stock Ideas</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/47397_binocular-01__w320__h240__.jpg&quot; alt=&quot;A hunt for quality large caps available cheap&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Following the recent correction, we went on a search for quality large-cap stocks</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/47397/a-hunt-for-quality-large-caps-available-cheap/</guid>
		</item>
		<item>
			<title>Steely discipline</title>
			<link>https://www.valueresearchonline.com/stories/35668/steely-discipline/</link>
			<pubDate>Thu, 17 May 2018 08:00:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/35668_mahesh-patil-1000x750__w320__h240__.jpg&quot; alt=&quot;Steely discipline&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Banking on a process driven approach, Mahesh Patil is an expert picker of growth opportunities</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/35668/steely-discipline/</guid>
		</item>
		<item>
			<title>Value your funds</title>
			<link>https://www.valueresearchonline.com/stories/35074/value-your-funds/</link>
			<pubDate>Mon, 29 Jan 2018 12:45:55 +0530</pubDate>
			<category>Fundwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/35074_20180129-fundwire-valuefunds-1000x750__w320__h240__.jpg&quot; alt=&quot;Value your funds&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Value funds have out-performed benchmark indices over the long-term as well as short-term</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/35074/value-your-funds/</guid>
		</item>
		<item>
			<title>More than meets the eye</title>
			<link>https://www.valueresearchonline.com/stories/34519/more-than-meets-the-eye/</link>
			<pubDate>Tue, 17 Oct 2017 13:38:21 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/34519_20171017-buyback__w320__h240__.jpg&quot; alt=&quot;More than meets the eye&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Buybacks since March 2016 don&#039;t seem to indicate that companies are trying to save on the dividend tax</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/34519/more-than-meets-the-eye/</guid>
		</item>
		<item>
			<title>The unusual five</title>
			<link>https://www.valueresearchonline.com/stories/33000/the-unusual-five/</link>
			<pubDate>Mon, 06 Feb 2017 07:14:18 +0530</pubDate>
			<category>Stockwire</category>
			<description>Did you know that out of about 2,000 companies listed on the NSE, only five stand out as consistently high performers? Read about them here></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/33000/the-unusual-five/</guid>
		</item>
		<item>
			<title>Who wins in India: Value or Growth?</title>
			<link>https://www.valueresearchonline.com/stories/31533/who-wins-in-india-value-or-growth/</link>
			<pubDate>Fri, 15 Jul 2016 13:12:10 +0530</pubDate>
			<category>Fundwire</category>
			<description>This comparison pits told old rivals against each other using MSCI India Indices. Time determines the answer></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/31533/who-wins-in-india-value-or-growth/</guid>
		</item>
		<item>
			<title>Does the stable dividend strategy outperform?</title>
			<link>https://www.valueresearchonline.com/stories/30818/does-the-stable-dividend-strategy-outperform/</link>
			<pubDate>Tue, 12 Apr 2016 15:59:37 +0530</pubDate>
			<category>Marketwire</category>
			<description>We compared total returns on the S&amp;P BSE Dividend Stability Index with the BSE Sensex, Nifty and other indices to find out whether the strategy really works></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/30818/does-the-stable-dividend-strategy-outperform/</guid>
		</item>
		<item>
			<title>Sun in the shade</title>
			<link>https://www.valueresearchonline.com/stories/30034/sun-in-the-shade/</link>
			<pubDate>Wed, 20 Jan 2016 12:46:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Sun Pharma has fallen some 40 per cent from its 52-week highs. What ails the country&#039;s largest pharmaceutical company and what&#039;s ahead></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/30034/sun-in-the-shade/</guid>
		</item>
		<item>
			<title>Going strong</title>
			<link>https://www.valueresearchonline.com/stories/29866/going-strong/</link>
			<pubDate>Wed, 06 Jan 2016 11:56:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Even though the USFDA created problems for large pharma companies, their smaller counterparts have been doing very well></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29866/going-strong/</guid>
		</item>
		<item>
			<title>Sunny days ahead</title>
			<link>https://www.valueresearchonline.com/stories/29602/sunny-days-ahead/</link>
			<pubDate>Fri, 11 Dec 2015 11:42:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>The fall in profitability after the Ranbaxy acquisition may have weighed  heavily upon investors but it&#039;s just a matter of time that the company turns around its acquisitions></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29602/sunny-days-ahead/</guid>
		</item>
		<item>
			<title>Small is beautiful in pharma</title>
			<link>https://www.valueresearchonline.com/stories/29589/small-is-beautiful-in-pharma/</link>
			<pubDate>Thu, 10 Dec 2015 11:38:29 +0530</pubDate>
			<category>Stockwire</category>
			<description>With high numbers of ANDAs, mid-rung pharma companies could outperform their larger peers in the future></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29589/small-is-beautiful-in-pharma/</guid>
		</item>
		<item>
			<title>Delivering big-bang growth</title>
			<link>https://www.valueresearchonline.com/stories/29569/delivering-big-bang-growth/</link>
			<pubDate>Wed, 09 Dec 2015 11:35:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Lupin started as a TB specialist and grew itself over the years through acquisitions. Things went on so well that it made its shareholders as rich as Croesus></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29569/delivering-big-bang-growth/</guid>
		</item>
		<item>
			<title>The most rewarding stocks of the decade</title>
			<link>https://www.valueresearchonline.com/stories/29480/the-most-rewarding-stocks-of-the-decade/</link>
			<pubDate>Mon, 30 Nov 2015 11:53:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Each of these companies has faced tough periods but each has overcome them. See what the future holds for these multibaggers></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29480/the-most-rewarding-stocks-of-the-decade/</guid>
		</item>
		<item>
			<title>The quest for value</title>
			<link>https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</link>
			<pubDate>Tue, 20 Oct 2015 17:56:55 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/29141_29141__w320__h240__.jpg&quot; alt=&quot;The quest for value&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</guid>
		</item>
		<item>
			<title>Companies operating with wide margins</title>
			<link>https://www.valueresearchonline.com/stories/28975/companies-operating-with-wide-margins/</link>
			<pubDate>Thu, 08 Oct 2015 12:19:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/28975_28975__w320__h240__.jpg&quot; alt=&quot;Companies operating with wide margins&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Companies that operate with such a high share of industry profits that their nearest competitors end up playing nothing more than second fiddle to them</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28975/companies-operating-with-wide-margins/</guid>
		</item>
		<item>
			<title>The Story that Dividends Tell</title>
			<link>https://www.valueresearchonline.com/stories/28467/the-story-that-dividends-tell/</link>
			<pubDate>Mon, 03 Aug 2015 04:03:00 +0530</pubDate>
			<category>Marketwire</category>
			<description>The history of dividends is a good window into companies&#039; financial strength &amp; can help build an investment case></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28467/the-story-that-dividends-tell/</guid>
		</item>
		<item>
			<title>Does opportunity buying work?</title>
			<link>https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</link>
			<pubDate>Wed, 24 Jun 2015 12:40:03 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/28229_28229__w320__h240__.jpg&quot; alt=&quot;Does opportunity buying work?&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Buying distressed stocks may not always yield good returns</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</guid>
		</item>
		<item>
			<title>The Money-maker</title>
			<link>https://www.valueresearchonline.com/stories/27832/the-money-maker/</link>
			<pubDate>Wed, 06 May 2015 11:49:56 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>No company across sectors can match the close to 40 per cent ten-year margins of Divi&#039;s Laboratories></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27832/the-money-maker/</guid>
		</item>
		<item>
			<title>The Sunshine Stock</title>
			<link>https://www.valueresearchonline.com/stories/27819/the-sunshine-stock/</link>
			<pubDate>Tue, 05 May 2015 12:41:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Sun Pharmaceutical Industries is the most profitable large pharma company, having consistently improved margins over the last decade></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27819/the-sunshine-stock/</guid>
		</item>
		<item>
			<title>India's Most Profitable Companies</title>
			<link>https://www.valueresearchonline.com/stories/27818/india-s-most-profitable-companies/</link>
			<pubDate>Tue, 05 May 2015 11:50:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>We look at ten companies that have maintained healthy profit margins over the years and analyse whether they are still a buy at current prices></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27818/india-s-most-profitable-companies/</guid>
		</item>
    </channel>
</rss>
